drugset / Trial / NCT02338752

Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient

NCT02338752 ↗

Phase 1/2 Completed 20 enrolled Fuda Cancer Hospital, Guangzhou
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safeness and effectiveness of mix vaccine (MV). Enrolled patients will receive standard treatment according to National Comprehensive Cancer Network (NCCN) guide line with or without combining MV injection. The efficacy and side effect will be compared between the two groups.

Timeline

Start
2015-01
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator mix vaccine Vaccine 0.5 ml Subcutaneous

Indications